Opko Health (OPK) Cash from Investing Activities (2010 - 2026)
Opko Health (OPK) posted Cash from Investing Activities of -$1.8 million for Q1 2026, up 12.02% quarter-over-quarter from -$2.0 million in Q4 2025, and down 104.44% year-on-year from $40.5 million in Q1 2025.
Opko Health (OPK) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Opko Health (OPK) has reported Cash from Investing Activities for 17 consecutive years, with -$1.8 million the latest figure, recorded in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$1.8 million, down 104.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $188.0 million (down 27.93% YoY), and the FY2025 annual result was $230.3 million, down 34.61% from the prior year.
- Cash from Investing Activities was -$1.8 million for Q1 2026 at Opko Health, up from -$2.0 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $236.2 million in Q3 2024 and troughed at -$11.6 million in Q2 2024.
- Average Cash from Investing Activities over 5 years is $32.6 million, with a median of -$3.2 million recorded in 2023.
- Year-over-year, Cash from Investing Activities plunged 343.31% in 2022 and surged 6713.3% in 2024.
- Over 5 years, Cash from Investing Activities stood at -$7.9 million in 2022, then surged by 81.99% to -$1.4 million in 2023, then soared by 16759.17% to $236.2 million in 2024, then sank by 100.87% to -$2.0 million in 2025, then advanced by 12.02% to -$1.8 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$1.8 million in Q1 2026, -$2.0 million in Q4 2025, and $194.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -32.14 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -77.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -196.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Opko Health | 1.16 Bn | 819.20 Mn | 45.76 Mn | -1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.80 Mn |
| Mar 31, 2026 | -1.80 Mn |
| Dec 31, 2025 | -2.05 Mn |
| Dec 31, 2025 | -2.05 Mn |
| Sep 30, 2025 | 194.65 Mn |
| Sep 30, 2025 | 194.65 Mn |
| Jun 30, 2025 | -2.83 Mn |
| Jun 30, 2025 | -2.83 Mn |
| Mar 31, 2025 | 40.53 Mn |
| Mar 31, 2025 | 40.53 Mn |
| Sep 30, 2024 | 236.23 Mn |
| Sep 30, 2024 | 236.23 Mn |
| Jun 30, 2024 | -11.56 Mn |
| Jun 30, 2024 | -11.56 Mn |
| Mar 31, 2024 | -4.40 Mn |
| Mar 31, 2024 | -4.40 Mn |
| Dec 31, 2023 | -1.42 Mn |
| Dec 31, 2023 | -1.42 Mn |
| Sep 30, 2023 | -3.57 Mn |
| Sep 30, 2023 | -3.57 Mn |